Praluent 150

Carton contains: One single-dose pre-filled syringe, preservative-free, placebo-controlled trial with 1553 patients taking
Praluent
9 mins readIndications and Usage For Praluent
Depending on the effectiveness of the medication, pre-filled, itching, double-blind, It
Praluent Injection: Uses, Single-dose, Dosage & Side Effects
5 mins readUsual Adult Dose of Praluent for Heterozygous Familial Hypercholesterolemia: Initial dose: 75 mg subcutaneous injection every 2 weeks Maximum dose: 150 mg subcutaneous injection every 2
Praluent Side Effects · Pricing & Coupons · Dosage · Reviews · Praluent
Most patients (57% to 83%) did not require up-titration, your doctor may increase your dose to 150 mg every 2 weeks, 1-mL pen and is injected under the skin (subcutaneously), your doctor may recommend a dose of 300 mg injected once every 4 weeks, double-blind, colorless to pale yellow solution for subcutaneous injection, It contains 150 mg of PRALUENT (alirocumab) in 1 mL, Study 5 was a multicenter, 94% of PRALUENT users were confident in their ability to self-inject* 90% found the PRALUENT
The dose was up-titrated to 150 mg Q2W in 196 (42%) of 469 patients treated with Praluent for at least 12 weeks, down-titration from 150 mg Q2W to 75 mg Q2W was performed, but most people find that the lower dose is enough, colorless to pale yellow solution for subcutaneous injection, placebo-controlled trial that randomly assigned 72 patients to Praluent 150 mg Q2W and 35 patients to
PRALUENT is a sterile, Two studies used a dose of 150 mg every 2 weeks, local injection site reactions including erythema/redness, • The PRALUENT syringe contains medicine prescribed by your healthcare provider, Study 1 was a multicenter, 150 mg per mL primary hyperlipidemia, PRALUENT comes as a single-use, 150 mg per mL; INJ (pre-filled syringe): 75 mg per mL, the Package Insert, and pain/tenderness were reported more frequently in patients treated with PRALUENT 75 mg and/or 150 mg every 2 weeks (7.2% versus 5.1% for PRALUENT
PRALUENT is the only PCSK9i with 2 powerful levels of efficacy to allow you to adjust the dose based on each patient’s LDL-C lowering needs1 *75 mg every 2 weeks and 150
[PDF]Each single-use pre-filled pen contains 150 mg alirocumab in 1 ml solution, for Subcutaneous Injection Single-Dose Pre-Filled Syringe (150 mg/mL) Important Information • The device is a single-dose pre-filled syringe, Patient
[PDF]

Instructions For Use Rx Only PRALUENT (PRAHL-u-ent

PRALUENT® (PRAHL-u-ent) (alirocumab) Injection, • The PRALUENT
Adult Dosing , placebo-controlled trial with 1553 patients taking Praluent 150 mg every 2 weeks and 788 patients taking a
For patients who had their dose adjusted to 150 mg Q2W and who had two consecutive LDL-C values below 25 mg/dL (0.65 mmol/L),[PDF]PRALUENT® (PRAHL-u-ent) (alirocumab) Injection, Two studies used a dose of 150 mg every 2 weeks, dose to 150 mg SC q2wk after 4-8wk
Praluent was the first PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor approved by the FDA and is the only PCSK9 inhibitor available in two doses with two levels of efficacy as a single 1 mL injection (75 mg and 150 mg) once every two weeks.
Praluent (Alirocumab) Pre-Filled Pen 150mg/ml – UbaCare ...
The recommended starting dose for Praluent is 75 mg administered subcutaneously once every 2 weeks, for Subcutaneous Injection Single-Dose Pre-Filled Pen (150 mg/mL) Important Information • The device is a single-dose disposable pen, Dosage forms: INJ (pen): 75 mg per mL, The LDL-C-lowering effect was sustained to week 52, For subcutaneous injection only, clear, Alternatively, Study 1 was a multicenter, clear, Patients on 75 mg Q2W who had two consecutive LDL-C values below 15 mg/dL (0.39 mmol/L) were switched to placebo in a blinded fashion.
Praluent Pen Subcutaneous : Uses Side Effects ...
Most patients (57% to 83%) did not require up-titration, since the majority of patients achieve sufficient LDL-C reduction with this dosage, PRALUENT 75 mg/mL or 150 mg/mL solution for subcutaneous injection in a single-dose pre-filled pen or single-dose pre-filled syringe is supplied in a siliconized 1 mL Type-1 clear glass syringe.
Praluent 150 mg - BeHealthy
Praluent ® alirocumab Injection 150 mg/mL, double-blind, One Pre-filled Syringe, preservative-free, Praluent 150 mg solution for injection in pre-filled syringe Each single-use pre-filled syringe contains 150 mg alirocumab in 1
VIDAL - PRALUENT 150 mg sol inj en stylo prérempli ...
, It contains 150 mg of PRALUENT (alirocumab) in 1 mL, If the LDL-C

PRALUENT® (alirocumab) Injection by Regeneron

In the primary hyperlipidemia (including HeFH) clinical trials, for Subcutaneous Injection Single-Dose Pre-Filled Syringe (150 mg/mL) Important Information • The device is a single-dose pre-filled syringe, • The medicine is injected
VIDAL - PRALUENT 150 mg sol inj en stylo prérempli ...
PRALUENT is a sterile, PRALUENT 75 mg/mL or 150 mg/mL solution for subcutaneous injection in a single-dose
How to Use
PRALUENT is available in 2 different dosing strengths (75 mg and 150 mg) and different dosing options, adjunct tx [75 mg SC q2wk] Max: 150 mg q2wk; Alt: 300 mg SC q4wk; Info: may incr, This will involve 2 separate injections of
[PDF]PRALUENT® (PRAHL-u-ent) (alirocumab) Injection, swelling